Trial · NCT03353753
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Progression-Free Survival (PFS) | Ripretinib | 27.6 | 95% Confidence Interval 20.0 to 29.9 | Weeks | |
| Progression-Free Survival (PFS) | Placebo | 4.1 | 95% Confidence Interval 4.0 to 7.3 | Weeks | |
| Objective Response Rate (ORR) | Ripretinib | 9.4 | 95% Confidence Interval 4.2 to 17.7 | Percentage of Participants | |
| Objective Response Rate (ORR) | Placebo | 0 | 95% Confidence Interval 0.0 to 8.0 | Percentage of Participants | |
| Time to Tumor Progression (TTP) Based on Independent Radiologic Review | Ripretinib | 28 | 95% Confidence Interval 20.0 to 36.4 | Weeks | |
| Time to Tumor Progression (TTP) Based on Independent Radiologic Review | Placebo | 4.1 | 95% Confidence Interval 4.0 to 7.6 | Weeks | |
| Overall Survival (OS) | Ripretinib | 65.6 | 95% Confidence Interval 53.6 to 65.6 | weeks | |
| Overall Survival (OS) | Placebo | 28.6 | 95% Confidence Interval 17.9 to 50.4 | weeks | |
| Quality of Life & Disease-Related Symptoms - European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer 30-Item - Role Functioning | Ripretinib | 3.5 | Standard Deviation 27.31 | units on a scale | |
| Quality of Life & Disease-Related Symptoms - European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Cancer 30-Item - Role Functioning | Placebo | -17.1 | Standard Deviation 30.28 | units on a scale | |
| Quality of Life & Disease-Related Symptoms - Physical Functioning | Ripretinib | 1.6 | Standard Deviation 16.03 | units on a scale | |
| Quality of Life & Disease-Related Symptoms - Physical Functioning | Placebo | -8.9 | Standard Deviation 19.28 | units on a scale | |
| Quality of Life & Disease-Related Symptoms - EuroQol Visual Analogue Scale | Ripretinib | 3.7 | Standard Deviation 20.36 | Units on a Scale | |
| Quality of Life & Disease-Related Symptoms - EuroQol Visual Analogue Scale | Placebo | -8.9 | Standard Deviation 19.31 | Units on a Scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03353753/results